NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
| Image |  |
|---|---|
| Description | scientific article published on 10 March 2020 |
| Author/s |
author: Ryan T Merrell Jeffrey J. Raizer Elizabeth R. Gerstner Lyndon J. Kim Merideth M Wendland James D Battiste David A Reardon John L Villano Eudocia Q Lee Kenneth D Aldape Edward Pan Naveed Wagle Steven J Chmura Patrick Y Wen Minesh Mehta |
| Publication date | March 10, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |